Literature DB >> 32060844

CCL7 Signaling in the Tumor Microenvironment.

Yeo Song Lee1, Yong Beom Cho2,3.   

Abstract

The tumor microenvironment is the primary location in which tumor cells and the host immune system interact. There are many physiological, biochemical, cellular mechanisms in the neighbor of tumor which is composed of various cell types. Interactions of chemokines and chemokine receptors can recruit immune cell subsets into the tumor microenvironment. These interactions can modulate tumor progression and metastasis. In this chapter, we will focus on chemokine (C-C motif) ligand 7 (CCL7) that is highly expressed in the tumor microenvironment of various cancers, including colorectal cancer, breast cancer, oral cancer, renal cancer, and gastric cancer. We reviewed how CCL7 can affect cancer immunity and tumorigenesis by describing its regulation and roles in immune cell recruitment and stromal cell biology.

Entities:  

Keywords:  Antitumor effect; CCL7; CCRs; Cancer-associated adipocytes; Cancer-associated fibroblast; Clinical trials; Combination treatment; Immune cell infiltration; Immunotherapy; Metastasis; Pro-tumor effect; Prognosis; Proliferation; Tumor microenvironment; Tumor-associated macrophage

Mesh:

Substances:

Year:  2020        PMID: 32060844     DOI: 10.1007/978-3-030-36667-4_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

Review 1.  Advances in Research on the Effects and Mechanisms of Chemokines and Their Receptors in Cancer.

Authors:  Jing Xu; Jing-Quan Li; Qi-Lei Chen; Elena A Shestakova; Vsevolod A Misyurin; Vadim S Pokrovsky; Elena M Tchevkina; Hu-Biao Chen; Hang Song; Jian-Ye Zhang
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

2.  CCL7 playing a dominant role in recruiting early OCPs to facilitate osteolysis at metastatic site of colorectal cancer.

Authors:  He Yang; Li Jian; Qian Jin; Kang Xia; Wang Cai-Ru; Sheng Jun; Huang Chen; Wang Wei; Song Ben-Jing; Li Shi-Hong; Long Shi-Wei; Wu Juan; Zheng Wei
Journal:  Cell Commun Signal       Date:  2022-06-17       Impact factor: 7.525

3.  Contact-dependent signaling triggers tumor-like proliferation of CCM3 knockout endothelial cells in co-culture with wild-type cells.

Authors:  Matthias Rath; Konrad Schwefel; Matteo Malinverno; Dariush Skowronek; Alexandra Leopoldi; Robin A Pilz; Doreen Biedenweg; Sander Bekeschus; Josef M Penninger; Elisabetta Dejana; Ute Felbor
Journal:  Cell Mol Life Sci       Date:  2022-06-04       Impact factor: 9.207

4.  miR-4759 suppresses breast cancer through immune checkpoint blockade.

Authors:  You-Zhe Lin; Shu-Hsuan Liu; Wan-Rong Wu; Yi-Chun Shen; Yuan-Liang Wang; Chien-Ching Liao; Pei-Le Lin; Han Chang; Liang-Chih Liu; Wei-Chung Cheng; Shao-Chun Wang
Journal:  Comput Struct Biotechnol J       Date:  2021-12-16       Impact factor: 7.271

Review 5.  Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease.

Authors:  Shaoping She; Liying Ren; Pu Chen; Mingyang Wang; Dongbo Chen; Ying Wang; Hongsong Chen
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

Review 6.  Thromboinflammatory Processes at the Nexus of Metabolic Dysfunction and Prostate Cancer: The Emerging Role of Periprostatic Adipose Tissue.

Authors:  Ibrahim AlZaim; Aya Al-Saidi; Safaa H Hammoud; Nadine Darwiche; Yusra Al-Dhaheri; Ali H Eid; Ahmed F El-Yazbi
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

7.  Connexin 37 Regulates the Kv1.3 Pathway and Promotes the Development of Atherosclerosis.

Authors:  Minqi Liao; Lihua Chen; Jiongbin Lu; Guangzhu Liang; Yongzhao Yao; Shumin Ouyang; Yanhua Yang; Zhengwei Jian; Suxia Guo
Journal:  Mediators Inflamm       Date:  2022-09-23       Impact factor: 4.529

8.  Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients.

Authors:  Guang-Zhi Zhang; Zuo-Long Wu; Chun-Ying Li; En-Hui Ren; Wen-Hua Yuan; Ya-Jun Deng; Qi-Qi Xie
Journal:  Front Mol Biosci       Date:  2021-05-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.